Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2007-07-31
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S254000
Reexamination Certificate
active
11230493
ABSTRACT:
The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
REFERENCES:
patent: 5620676 (1997-04-01), Jacobson et al.
patent: 6251910 (2001-06-01), Guile et al.
patent: 96/29345 (1996-09-01), None
patent: 97/19170 (1997-05-01), None
Jin et al, “Molecular Basis for ADP-induced Platelet Activation,” The Journal of Biological Chemistry, vol. 273, No. 4, pp. 2030-2034(1998).
Puri et al, “Modulation of Platelet Responses by 2-[3-(Bromo-2-oxopropylthio)]adenosine . . . ,” Archives of Biochemistry and Biophysics, vol. 343, No. 1, pp. 140-145 (1997).
A. David Rodrigues; Commentary, “Use of in Vitro Human Metabolism Studies in Drug Development; Biochemical Pharmacology”, vol. 48, No. 12, pp. 2147-2156, 1994.
Mistry, et al; “Glucuronidation In Vitro and In Vivo Comparison of Intestinal and Hepatic Conjugation of Morphine, Naloxone, and Buprenorphine; The American Society for Pharmacology and Experimental Therapeutics”; vol. 15, No. 5; pp. 710-717; 1987.
J. Brian Houston; Commentary, “Utility of In Vitro Drug Metabolism Data in Predicting In Vivo Metabolic Clearance; Biochemical Pharmacology”, vol. 47, No. 9, pp. 1469-1479, 1994.
Martindale Thirty-third edition; “The Complete Drug Reference”; Pharmaceutical Press; pp. 1086-1089.
Awni, et al; “The Effect of Mild or Moderate Hepatic Impairment (Cirrhosis) on the Pharmacokinetics of Zileuton”; Clin. Pharacokinet, 29 (Suppl. 2): 49-61, 1995.
Guile Simon
Hardern David
Ingall Anthony
Springthorpe Brian
Willis Paul
AstraZeneca AB
Berch Mark L.
Moore Susanna
Nixon & Vanderhye
LandOfFree
Trisubstituted triazolopyrimidines for use in platelet... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted triazolopyrimidines for use in platelet..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted triazolopyrimidines for use in platelet... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3819823